B
Bloomios Inc
OTC:BLMS
Bloomios Inc
OTC:BLMS
Price:
0.0001
USD
Market Cap:
$10k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
K
|
Kespion Co Ltd
KOSDAQ:079190
|
KR |
|
O
|
Organon Pharma Indonesia Tbk PT
IDX:SCPI
|
ID |
Income Statement
Earnings Waterfall
Bloomios Inc
Bloomios Inc
Income Statement
Bloomios Inc
Bloomios Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
|
| Revenue |
4
N/A
|
6
+67%
|
8
+37%
|
8
+4%
|
8
-8%
|
7
-15%
|
6
-15%
|
6
+8%
|
7
+21%
|
9
+19%
|
8
-6%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(2)
|
(3)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
|
| Gross Profit |
1
N/A
|
3
+81%
|
3
+33%
|
4
+9%
|
3
-10%
|
3
-13%
|
3
-9%
|
2
-17%
|
2
+2%
|
2
+3%
|
2
-12%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(8)
|
(8)
|
(6)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(1)
N/A
|
(1)
+48%
|
(1)
-11%
|
(0)
+34%
|
(1)
-161%
|
(2)
-141%
|
(3)
-32%
|
(4)
-15%
|
(5)
-50%
|
(6)
-5%
|
(4)
+27%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(1)
|
(8)
|
(9)
|
(9)
|
(10)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
(26)
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(3)
N/A
|
(2)
+21%
|
(3)
-13%
|
(2)
+23%
|
(2)
+16%
|
(3)
-94%
|
(5)
-55%
|
(14)
-170%
|
(15)
-11%
|
(16)
-7%
|
(40)
-146%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(5)
|
(14)
|
(15)
|
(16)
|
(40)
|
|
| Net Income (Common) |
(3)
N/A
|
(2)
+21%
|
(3)
-13%
|
(2)
+23%
|
(2)
+16%
|
(3)
-94%
|
(5)
-55%
|
(14)
-170%
|
(15)
-11%
|
(16)
-7%
|
(40)
-146%
|
|
| EPS (Diluted) |
-0.23
N/A
|
-0.09
+61%
|
-0.22
-144%
|
-0.16
+27%
|
-0.15
+6%
|
-0.26
-73%
|
-0.39
-50%
|
-1.04
-167%
|
-0.6
+42%
|
-0.64
-7%
|
-0.65
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
